Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 44 Neoplasm Metastasis 19 Liver Neoplasms 18 Colorectal Neoplasms 15 Cholangiocarcinoma 11 Pancreatic Neoplasms 9 Lung Neoplasms 9 Colonic Neoplasms 9 Breast Neoplasms 8 Carcinoma, Renal Cell 7 Carcinoma, Non-Small-Cell Lung 7 Barrett Esophagus 7 Thyroid Nodule 6 Recurrence 6 Rectal Neoplasms 6 Thyroid Neoplasms 5 Pain 4 Neoplasms 4 Kidney Neoplasms 4 Esophageal Neoplasms 4 Thyroid Cancer, Papillary 3 Prostatic Neoplasms 3 Leiomyoma 3 Biliary Tract Neoplasms 3 Bile Duct Neoplasms 3 Agnosia 3 Thyroid Diseases 2 Hyperaldosteronism 2 Hepatitis B 2 Gallbladder Neoplasms 2

Interventions

relacorilant 5 Osilodrostat 4 Mifepristone 4 Corlux 3 pasireotide 2 Metyrapone 2 pembrolizumab 1 Staining and Labeling 1 Radiofrequency Ablation 1 Kangaroo-Mother Care Method 1 Forest Therapy 1 Blood Specimen Collection 1 ASP3662 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

ACTH Syndrome, Ectopic × Radiofrequency Ablation × Clear all

NCT02756754 2026-05-04

ADERADHTA

University Hospital, Toulouse

Phase NA Completed

ACTH Syndrome, Ectopic, Hyperaldosteronism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡